Thomas L. Ortel

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 81 Citations 30,512 367 World Ranking 11229 National Ranking 5884

Overview

What are the main themes of his work throughout his whole career to date

Combining a variety of fields, including Hazard ratio, Confidence interval and Proportional hazards model, are what the author presents in his essays. He combines Confidence interval and Hazard ratio in his studies. His research on Proportional hazards model frequently connects to adjacent areas such as Surgery. Surgery is often connected to Chemotherapy regimen in his work. His Clinical trial research spans across into areas like Clinical study design and Clinical research. In his study, he carries out multidisciplinary Clinical research and Clinical trial research. While working in this field, he studies both Internal medicine and Intensive care medicine. Thomas L. Ortel incorporates Intensive care medicine and Internal medicine in his studies. Thomas L. Ortel undertakes interdisciplinary study in the fields of Cancer and Chemotherapy regimen through his research.

Thomas L. Ortel most often published in these fields:

Internal medicine (100.00%)
Hazard ratio (50.00%)
Chemotherapy regimen (50.00%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Prevention of VTE in Nonsurgical Patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Yngve Falck-Ytter;Charles W. Francis;Norman A. Johanson;Catherine Curley.
Chest (2012)

3284 Citations

Prevention of VTE in Orthopedic Surgery Patients

Yngve Falck-Ytter;Charles W. Francis;Norman A. Johanson;Catherine Curley.
Chest (2012)

1801 Citations

Update of the guidelines for lupus anticoagulant detection

Vittorio Pengo;Armando Tripodi;G. Reber;Jacob H. Rand.
Journal of Thrombosis and Haemostasis (2009)

1111 Citations

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation

Abstr Act;James D. Douketis;Alex C. Spyropoulos;Scott Kaatz.
The New England Journal of Medicine (2015)

1082 Citations

Venous Thromboembolism: A Public Health Concern

Michele G Beckman;W Craig Hooper;Sara E Critchley;Thomas L Ortel.
American Journal of Preventive Medicine (2010)

1042 Citations

Clinical practice. Heparin-induced thrombocytopenia.

Gowthami M. Arepally;Thomas L. Ortel.
The New England Journal of Medicine (2006)

999 Citations

Heparin-Induced Thrombocytopenia

Gowthami M. Arepally;Thomas L. Ortel.
The New England Journal of Medicine (2006)

988 Citations

von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

W. L. Nichols;M. B. Hultin;A. H. James;M. J. Manco‐Johnson.
Haemophilia (2008)

927 Citations

Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies

Barton F. Haynes;Judith Fleming;E. William St. Clair;Herman Katinger.
Science (2005)

890 Citations

A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing

Stephen E. Kimmel;Benjamin French;Scott E. Kasner;Julie A. Johnson.
The New England Journal of Medicine (2013)

789 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Thomas L. Ortel